Dennis Gurgen
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers.
Journal: Cancer research
Published: November 19, 2025
Drug targeting of the monocarboxylate transporter MCT4 is a novel treatment strategy for metastatic ccRCC.
Journal: Pharmacological research
Published: September 23, 2025
Ex vivo drug sensitivity profiling to complement molecular profiling in pediatric precision oncology.
Journal: NPJ precision oncology
Published: July 23, 2025
Ex vivo drug sensitivity profiling to complement molecular profiling in pediatric precision oncology.
Journal: NPJ precision oncology
Published: July 23, 2025
Oncogene Silencing via ecDNA Micronucleation.
Journal: bioRxiv : the preprint server for biology
Published: May 05, 2025
Serially Quantifying TERT Rearrangement Breakpoints in ctDNA Enables Minimal Residual Disease Monitoring in Patients with Neuroblastoma.
Journal: Cancer research communications
Published: November 23, 2024
Passenger Gene Coamplifications Create Collateral Therapeutic Vulnerabilities in Cancer.
Journal: Cancer discovery
Published: October 10, 2023
Sex-specific molecular signature of mouse podocytes in homeostasis and in response to pharmacological challenge with rapamycin.
Journal: Biology of sex differences
Published: April 26, 2023
Inhibition of osteosarcoma by European Mistletoe derived val-miR218.
Journal: Extracellular vesicles and circulating nucleic acids
Published: February 18, 2023
Elimusertib has Antitumor Activity in Preclinical Patient-Derived Pediatric Solid Tumor Models.
Journal: Molecular cancer therapeutics
Published: February 13, 2023
Single-cell profiling of alveolar rhabdomyosarcoma reveals RAS pathway inhibitors as cell-fate hijackers with therapeutic relevance.
Journal: Science advances
Published: February 08, 2023
Last Updated: 09/26/2026